| Escherichia coli from animal reservoirs as a potential source of human extraintestinal pathogenic E. coli L Bélanger, A Garenaux, J Harel, M Boulianne, E Nadeau, CM Dozois FEMS Immunology & Medical Microbiology 62 (1), 1-10, 2011 | 401 | 2011 |
| Efficacy of a single oral dose of a live bivalent E. coli vaccine against post-weaning diarrhea due to F4 and F18-positive enterotoxigenic E. coli E Nadeau, JM Fairbrother, J Zentek, L Bélanger, D Tremblay, ... The Veterinary Journal 226, 32-39, 2017 | 74 | 2017 |
| Null mutations in Sinorhizobium meliloti exoS and chvI demonstrate the importance of this two‐component regulatory system for symbiosis L Bélanger, KA Dimmick, JS Fleming, TC Charles Molecular microbiology 74 (5), 1223-1237, 2009 | 70 | 2009 |
| Immunogenicity and protective efficacy of a single-dose live non-pathogenic Escherichia coli oral vaccine against F4-positive enterotoxigenic Escherichia coli challenge in pigs JM Fairbrother, É Nadeau, L Bélanger, CL Tremblay, D Tremblay, ... Vaccine 35 (2), 353-360, 2017 | 63 | 2017 |
| Production of heterologous protein by Methylobacterium extorquens in high cell density fermentation L Bélanger, MM Figueira, D Bourque, L Morel, M Béland, L Laramée, ... FEMS microbiology letters 231 (2), 197-204, 2004 | 60 | 2004 |
| Production of an Insecticidal Crystal Protein from Bacillus thuringiensis by the Methylotroph Methylobacterium extorquens YJ Choi, JL Gringorten, L Bélanger, L Morel, D Bourque, L Masson, ... Applied and environmental microbiology 74 (16), 5178-5182, 2008 | 26 | 2008 |
| Members of the Sinorhizobium meliloti ChvI regulon identified by a DNA binding screen L Bélanger, TC Charles BMC microbiology 13, 1-13, 2013 | 20 | 2013 |
| Methylotrophic bacterium for the production of recombinant proteins and other products M Figueira, L Laramee, J Murrell, L Belanger, D Groleau, C Miguez US Patent App. 09/998,631, 2003 | 7 | 2003 |
| Methylotrophic bacterium for the production of recombinant proteins and other products M Figueira, L Laramee, D Bourque, L Belanger, D Groleau, L Morel, ... US Patent App. 10/188,746, 2003 | 6 | 2003 |
| Field efficacy of Coliprotec® F4, live oral vaccine against post-weaning diarrhoea caused by F4-enterotoxigenic E. coli (F4-ETEC) E Nadeau, D Tremblay, L Bélanger, D Cvejić, K Bauer, C Schneider, ... German pig farms. 24th International Pig Veterinary Congress, 2016 | 5 | 2016 |
| The Sinorhizobium meliloti ExoS/ChvI two-component regulatory system L Bélanger University of Waterloo, 2009 | | 2009 |
| Development of Methylobacterium extorquens as a recombinant protein production system and the expression of the heterologous cry1Aa gene from Bacillus thuringiensis L Bélanger McGill University, 2003 | | 2003 |
Charles M. DozoisINRS-Centre Armand-Frappier and Institut Pasteur International NetworkVerified email at inrs.ca
